{
  "resourceType" : "CodeSystem",
  "id" : "research-study-purpose-type",
  "meta" : {
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]
  },
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem research-study-purpose-type</b></p><a name=\"research-study-purpose-type\"> </a><a name=\"hcresearch-study-purpose-type\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"http://hl7.org/fhir/R5/shareablecodesystem.html\">Shareable CodeSystem</a></p></div><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/research-study-purpose-type</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">treatment<a name=\"research-study-purpose-type-treatment\"> </a></td><td>Treatment Study</td><td>One or more interventions are being evaluated for treating a disease, syndrome, or condition.</td></tr><tr><td style=\"white-space:nowrap\">prevention<a name=\"research-study-purpose-type-prevention\"> </a></td><td>Prevention Study</td><td>One or more interventions are being evaluated for preventing the development of a disease or condition.</td></tr><tr><td style=\"white-space:nowrap\">diagnostic<a name=\"research-study-purpose-type-diagnostic\"> </a></td><td>Diagnostic Study</td><td>One or more methods are being evaluated for use in detecting a disease or condition, typically in persons who have symptoms or signs of the condition. For example, a mammography to evaluate a palpable mass.</td></tr><tr><td style=\"white-space:nowrap\">screening<a name=\"research-study-purpose-type-screening\"> </a></td><td>Screening Study</td><td>One or more methods are being evaluated for use in detecting a disease or condition, in people who do not yet show symptoms or signs of the condition. For example, a mammography every 2 years in a woman with no current breast concerns.</td></tr><tr><td style=\"white-space:nowrap\">supportive-care<a name=\"research-study-purpose-type-supportive-care\"> </a></td><td>Supportive Care Study</td><td>One or more interventions are being evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function.</td></tr><tr><td style=\"white-space:nowrap\">health-services-research<a name=\"research-study-purpose-type-health-services-research\"> </a></td><td>Health Services Research</td><td>An investigation for evaluating the delivery, processes, management, organization, or financing of health care.</td></tr><tr><td style=\"white-space:nowrap\">basic-science<a name=\"research-study-purpose-type-basic-science\"> </a></td><td>Basic Science</td><td>An investigation to increase general scientific knowledge, such as examining the mechanism of action (for example, physiology or biomechanics) of a disease process or intervention.</td></tr><tr><td style=\"white-space:nowrap\">device-feasibility<a name=\"research-study-purpose-type-device-feasibility\"> </a></td><td>Device Feasibility Study</td><td>An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial.</td></tr><tr><td style=\"white-space:nowrap\">safety<a name=\"research-study-purpose-type-safety\"> </a></td><td>Safety Study</td><td>One or more interventions are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)</td></tr><tr><td style=\"white-space:nowrap\">risk-association<a name=\"research-study-purpose-type-risk-association\"> </a></td><td>Risk Association Study</td><td>One or more conditions or non-interventional exposures are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)</td></tr><tr><td style=\"white-space:nowrap\">efficacy<a name=\"research-study-purpose-type-efficacy\"> </a></td><td>Efficacy Study</td><td>One or more interventions are being evaluated for how well they achieve their intended purpose, such as the ability to treat or prevent a disease, syndrome, or condition.</td></tr><tr><td style=\"white-space:nowrap\">pharmacokinetic<a name=\"research-study-purpose-type-pharmacokinetic\"> </a></td><td>Pharmacokinetic Study</td><td>A study of the process or processes by which a drug is absorbed, distributed, metabolized, or eliminated by the body.</td></tr><tr><td style=\"white-space:nowrap\">pharmacodynamic<a name=\"research-study-purpose-type-pharmacodynamic\"> </a></td><td>Pharmacodynamic Study</td><td>A study of the mechanism of drug action, biochemical effect, or physiological effect of a drug.</td></tr><tr><td style=\"white-space:nowrap\">bioequivalence<a name=\"research-study-purpose-type-bioequivalence\"> </a></td><td>Bioequivalence Study</td><td>A study comparing two drug formulations to evaluate similarity in pharmacokinetic effects to determine if they are therapeutically interchangeable.</td></tr><tr><td style=\"white-space:nowrap\">dose-response<a name=\"research-study-purpose-type-dose-response\"> </a></td><td>Dose-Response Study</td><td>A study evaluating the relationship between the amount of a substance or degree of exposure and the resulting effect or biological response.</td></tr><tr><td style=\"white-space:nowrap\">pharmacogenetic<a name=\"research-study-purpose-type-pharmacogenetic\"> </a></td><td>Pharmacogenetic Study</td><td>A study evaluating how specific gene variations affect individual drug responses.</td></tr><tr><td style=\"white-space:nowrap\">pharmacogenomic<a name=\"research-study-purpose-type-pharmacogenomic\"> </a></td><td>Pharmacogenomic Study</td><td>A study evaluating how multiple gene variations affect individual drug responses.</td></tr><tr><td style=\"white-space:nowrap\">pharmacoeconomic<a name=\"research-study-purpose-type-pharmacoeconomic\"> </a></td><td>Pharmacoeconomic Study</td><td>A study evaluating the economic costs and value of a drug. This may include cost-effectiveness, cost-benefit, and cost-utility analyses.</td></tr><tr><td style=\"white-space:nowrap\">incidence<a name=\"research-study-purpose-type-incidence\"> </a></td><td>Incidence Study</td><td>A study that assesses the occurrence of new cases of disease, condition, or injury in a defined population over a specified period of time.</td></tr><tr><td style=\"white-space:nowrap\">prevalence<a name=\"research-study-purpose-type-prevalence\"> </a></td><td>Prevalence Study</td><td>A study that assesses the proportion of members of a population who have a particular disease, condition, or injury at a specified point in time or over a specified period of time.</td></tr><tr><td style=\"white-space:nowrap\">prediction<a name=\"research-study-purpose-type-prediction\"> </a></td><td>Prediction Study</td><td>One or more methods are being evaluated for use in predicting the risk of a disease or condition.</td></tr></table></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode" : "brr"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
    "valueInteger" : 1
  }],
  "url" : "http://terminology.hl7.org/CodeSystem/research-study-purpose-type",
  "version" : "1.0.0",
  "name" : "ResearchStudyPurposeType",
  "title" : "Research Study Purpose Type",
  "status" : "active",
  "experimental" : false,
  "date" : "2026-04-14T16:55:11+11:00",
  "publisher" : "Health Level Seven International",
  "contact" : [{
    "telecom" : [{
      "system" : "url",
      "value" : "http://hl7.org"
    },
    {
      "system" : "email",
      "value" : "hq@HL7.org"
    }]
  }],
  "description" : "Codes for the intent of the study.",
  "copyright" : "This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license",
  "caseSensitive" : true,
  "valueSet" : "http://terminology.hl7.org/ValueSet/research-study-purpose-type",
  "content" : "complete",
  "concept" : [{
    "code" : "treatment",
    "display" : "Treatment Study",
    "definition" : "One or more interventions are being evaluated for treating a disease, syndrome, or condition."
  },
  {
    "code" : "prevention",
    "display" : "Prevention Study",
    "definition" : "One or more interventions are being evaluated for preventing the development of a disease or condition."
  },
  {
    "code" : "diagnostic",
    "display" : "Diagnostic Study",
    "definition" : "One or more methods are being evaluated for use in detecting a disease or condition, typically in persons who have symptoms or signs of the condition. For example, a mammography to evaluate a palpable mass."
  },
  {
    "code" : "screening",
    "display" : "Screening Study",
    "definition" : "One or more methods are being evaluated for use in detecting a disease or condition, in people who do not yet show symptoms or signs of the condition. For example, a mammography every 2 years in a woman with no current breast concerns."
  },
  {
    "code" : "supportive-care",
    "display" : "Supportive Care Study",
    "definition" : "One or more interventions are being evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function."
  },
  {
    "code" : "health-services-research",
    "display" : "Health Services Research",
    "definition" : "An investigation for evaluating the delivery, processes, management, organization, or financing of health care."
  },
  {
    "code" : "basic-science",
    "display" : "Basic Science",
    "definition" : "An investigation to increase general scientific knowledge, such as examining the mechanism of action (for example, physiology or biomechanics) of a disease process or intervention."
  },
  {
    "code" : "device-feasibility",
    "display" : "Device Feasibility Study",
    "definition" : "An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial."
  },
  {
    "code" : "safety",
    "display" : "Safety Study",
    "definition" : "One or more interventions are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)"
  },
  {
    "code" : "risk-association",
    "display" : "Risk Association Study",
    "definition" : "One or more conditions or non-interventional exposures are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)"
  },
  {
    "code" : "efficacy",
    "display" : "Efficacy Study",
    "definition" : "One or more interventions are being evaluated for how well they achieve their intended purpose, such as the ability to treat or prevent a disease, syndrome, or condition."
  },
  {
    "code" : "pharmacokinetic",
    "display" : "Pharmacokinetic Study",
    "definition" : "A study of the process or processes by which a drug is absorbed, distributed, metabolized, or eliminated by the body."
  },
  {
    "code" : "pharmacodynamic",
    "display" : "Pharmacodynamic Study",
    "definition" : "A study of the mechanism of drug action, biochemical effect, or physiological effect of a drug."
  },
  {
    "code" : "bioequivalence",
    "display" : "Bioequivalence Study",
    "definition" : "A study comparing two drug formulations to evaluate similarity in pharmacokinetic effects to determine if they are therapeutically interchangeable."
  },
  {
    "code" : "dose-response",
    "display" : "Dose-Response Study",
    "definition" : "A study evaluating the relationship between the amount of a substance or degree of exposure and the resulting effect or biological response."
  },
  {
    "code" : "pharmacogenetic",
    "display" : "Pharmacogenetic Study",
    "definition" : "A study evaluating how specific gene variations affect individual drug responses."
  },
  {
    "code" : "pharmacogenomic",
    "display" : "Pharmacogenomic Study",
    "definition" : "A study evaluating how multiple gene variations affect individual drug responses."
  },
  {
    "code" : "pharmacoeconomic",
    "display" : "Pharmacoeconomic Study",
    "definition" : "A study evaluating the economic costs and value of a drug. This may include cost-effectiveness, cost-benefit, and cost-utility analyses."
  },
  {
    "code" : "incidence",
    "display" : "Incidence Study",
    "definition" : "A study that assesses the occurrence of new cases of disease, condition, or injury in a defined population over a specified period of time."
  },
  {
    "code" : "prevalence",
    "display" : "Prevalence Study",
    "definition" : "A study that assesses the proportion of members of a population who have a particular disease, condition, or injury at a specified point in time or over a specified period of time."
  },
  {
    "code" : "prediction",
    "display" : "Prediction Study",
    "definition" : "One or more methods are being evaluated for use in predicting the risk of a disease or condition."
  }]
}